Effect of ERK inhibitor on pulmonary metastasis of inoculated human adenoid cystic carcinoma cells in nude mice

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 109, Issue 1, 2010, Pages 117-123

  Hu, Ji an ^a   Li, Yining ^a   Fang, Jinhua ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 72049118700     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2009.07.052     Document Type: Article

References (34)

1. Verheyen E.M. Opposing effects of Wnt and MAPK on BMP/Smad signal duration. Dev Cell 13 (2007) 755-756
2. Junttila M.R., Li S.P., and Westermarck J. Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. FASEB J 22 (2008) 954-965
3. Sundaram M.V. RTK/Ras/MAPK signaling. WormBook 11 (2006) 1-19
4. Salh B., Marotta A., Matthewson C., Ahluwalia M., Flint J., and Owen D. Investigation of the Med-MAP kinase-Rsk pathway in human breast cancer. Anticancer Res 19 (1999) 731-740
5. Robinson M.J., Xu Be B.E., Stippec S., and Cobb M.H. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 9 (1997) 180-186
6. Garrington T.P., and Johnson G.L. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr Opin Cell Biol 11 (1999) 211-218
7. Johnson G.L., and Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298 (2002) 1911-1912
8. Shapiro P.S., and Ahn N.G. Feedback regulation of Raf-l and mitogen activated protein (MAP) kinase kinases l and 2 by MAP kinase phosphatase-1 (MKP-1). J Biol Chem 273 (1998) 1788-1793
9. Eveson J.W., Auclair P., Gnepp D.R., and EI-Naggar A.K. Tumors of the salivary glands. In: Barnes L., Eveson J.W., Reichart P., and Sidransky D. (Eds). World Health Organization classification of tumours. Pathology and genetics of head and neck tumours (2005), IARC Press, Lyon 221-222
10. Ito Y., Sasaki Y., Horimoto M., Wada S., Tanaka Y., Kasahara A., et al. Activation of mitogen-activated protein kinases/extracellular signal regulated kinases in human hepatocellular carcinoma. Hepatology 27 (1998) 951-958
11. Adeyinka A., Nui Y., Cherlet T., Snell L., Watson P.H., and Murphy L.C. Activated mitogen activated protein kinase expression during human breast tumorigenesis and breast cancer progression. Clin Cancer Res 8 (2002) 1747-1753
12. Albanell J., Codony-Servat J., Rojo F., Del Campo J.M., Sauleda S., Anido J., et al. Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by antiepidermal growth factor receptor treatments. Cancer Res 61 (2001) 6500-6510
13. Uzgare A.R., Kaplan P.J., and Greenberg N.M. Differential expression and/or activation of P38MAPK, ERKl/2, and JNK during the initiation and progression of prostate cancer. Prostate 55 (2003) 128-139
14. Oka H., Chatani Y., Hoshino R., Ogawa O., Kakehi Y., Terachi T., et al. Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. Cancer Res 55 (1995) 4182-4187
15. Gao J., Qian S., Li B., and Chen X. [Experimental study on tumor metastasis after treatment by hematoporphyrin derivative and laser]. Chin J oncol 8 (1986) 256-258 Chinese
16. Ahmed N., Pansino F., Baker M., Rice G., and Quinn M. Association between avb6 integrin expression, elevated p42/44 kDa MAPK, and plasminogen-dependent matrix degradation in ovarian cancer. J Cell Biochem 84 (2002) 675-686
17. Tsuboi Y., Ichida T., Sugitani S., Genda T., Inayoshi J., and Takamura M. Overexpression of extracellular signal-regulated protein kinase and its correlation with proliferation in human hepatocellular carcinoma. Liver Int 24 (2004) 432-436
18. Handra-Luca A., Bilal H., Bertrand J.C., and Fouret P. Extra-cellular signal-regulated ERK-1/ERK-2 pathway activation in human salivary gland mucoepidermoid carcinoma: association to aggressive tumor behavior and tumor cell proliferation. Am J Pathol 163 (2003) 957-967
19. Lee Jr. J.T., and Mccubrey J.A. The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia. Leukemia 16 (2002) 486-507
20. Dudley D.T., Pang L., Decker S.J., Bridges A.J., and Saltiel A.R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A 92 (1995) 7686-7689
21. Pagès G., Lenormand P., L'Allemain G., Chambard J.C., Meloche S., and Pouysségur J. Mitogen-activated protein kinases p42MAPK and p44MAPK are required for fibroblast proliferation. Proc Natl Acad Sci U S A 90 (1993) 8319-8323
22. Eliceiri B.P., Klemke R., Strömblad S., and Cheresh D.A. Integrin alphaνbeta3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis. J Cell Biol 140 (1998) 1255-1263
23. Pang L., Sawada T., Decker S.J., and Saltiel A.R. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J Biol Chem 270 (1995) 13585-13588
24. Finlay D., Healy V., Furlong F., O'Connell F.C., Keon N.K., and Martin F. MAP kinase pathway signalling is essential for extracellular matrix determined mammary epithelial cell survival. Cell Death Differ 7 (2000) 302-313
25. Holmström T.H., Tran S.E., Johnson V.L., Ahn N.G., Chow S.C., and Eriksson J.E. Inhibition of mitogen-activated kinase signaling sensitizes HeLa cells to Fas receptor-mediated apoptosis. Mol Cell Biol 19 (1999) 5991-6002
26. Yamaguchi K., Tomita H., Sugano E., Nakazawa T., and Tamai M. MAP kinase inhibitor, PD98059, inhibits rat RPE cell replication by cell cycle arrest. Invest Ophthalmol Vis Sci 43 (2002) 4515-4522
27. Seddighzadeh M., Zhou J.N., Kronenwett U., Shoshan M.C., Auer G., Sten-Linder M., et al. ERK signaling in metastatic human MDAMB-231 breast carcinoma cells is adapted to obtain high urokinase expression and rapid cell proliferation. Clin Exp Metastasis 17 (1999) 649-654
28. Maher P. P38 mitogen-activated protein kinase activation is required for fibroblast growth factor-2-stimulated cell proliferation but not differentiation. J Bio Chem 274 (1999) 17491-17498
29. Hoshi S., Goto M., Koyama N., Nomoto K., and Tanaka H. Regulation of vascular smooth muscle cell proliferation by nuclear factor-κb and its inhibitor, I-kB. J Bio Chem 275 (2000) 883-889
30. Zheng C.F., and Guan K.L. Cytoplasmic localization of the mitogen-activated protein kinase activator MEK. J Biol Chem 269 (1994) 19947-19952
31. Reddy K.B., Krueger J.S., Kondapaka S.B., and Diglio C.A. Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-9) in breast epithelial cells. Int J Cancer 82 (1999) 268-273
32. Simon C., Hicks M.J., Nemechek A.J., Mehta R., O'Malley Jr. B.W., Goepfert H., et al. PD98059, an inhibitor of ERK1 activation, attenuates the in vivo invasiveness of head and neck squamous cell carcinoma. Br J Cancer 80 (1999) 1412-1419
33. Lakka S.S., Jasti S.L., Gondi C., Boyd D., Chandrasekar N., Dinh D.H., et al. Down regulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro. Oncogene 21 (2002) 5601-5608
34. Webb C.P., Van Aelst L., Wigler M.H., and Woude G.F. Signaling pathways in Ras-mediated tumorigenicity and metastasis. Proc Natl Acad Sci U S A 95 (1998) 8773-8778